# DPPA5

## Overview
DPPA5, or developmental pluripotency associated 5, is a gene that encodes a protein integral to the maintenance of pluripotency in stem cells. The DPPA5 protein is primarily localized in the cytoplasm and is involved in RNA binding, which plays a crucial role in regulating gene expression and cellular processes necessary for preserving stem cell characteristics (Lagarkova2006Diverse; Galán2010Functional). It is particularly active during early embryonic development, where it contributes to embryonic genome activation and the degradation of maternal transcripts, processes vital for the transition from maternal to zygotic control of development (Galán2010Functional). The protein is subject to regulation by the ubiquitin E3 ligase FBXO9, which targets it for ubiquitination and degradation, thereby modulating its role in pluripotency (Swenson2024Ubiquitin). DPPA5 is expressed in pluripotent cells and tissues but is absent in normal somatic tissues, underscoring its specificity to stem cell biology and its potential significance in regenerative medicine and developmental biology (Lagarkova2006Diverse).

## Function
DPPA5 (developmental pluripotency associated 5) is a gene that encodes a protein crucial for maintaining pluripotency in stem cells. It plays a significant role in early embryonic development by regulating cell differentiation and proliferation. The protein is primarily active in the cytoplasm and is associated with RNA binding, influencing gene expression and cellular processes essential for maintaining stem cell characteristics (Lagarkova2006Diverse; Galán2010Functional).

In human embryonic stem cells (hESCs), DPPA5 is part of a gene signature that characterizes blastomeres, indicating its role in maintaining undifferentiation and immortality (Galán2010Functional). It is involved in embryonic genome activation (EGA) and maternal transcript degradation, processes critical for early development (Galán2010Functional). DPPA5 is also regulated by the ubiquitin E3 ligase FBXO9, which targets it for ubiquitination and degradation, thereby influencing pluripotency (Swenson2024Ubiquitin).

The protein's expression is detected in pluripotent cells and tissues but not in normal somatic tissues, highlighting its specificity to stem cell biology (Lagarkova2006Diverse). DPPA5's regulation and expression patterns suggest it is a key player in the maintenance of pluripotency and early embryonic development.

## Interactions
DPPA5, also known as developmental pluripotency associated 5, is involved in maintaining pluripotency in embryonic stem cells. It interacts with the ubiquitin E3 ligase FBXO9, which targets DPPA5 for ubiquitination and subsequent degradation. This interaction is crucial for regulating pluripotency, as FBXO9-mediated degradation of DPPA5 affects the expression of pluripotency factors. The interaction between DPPA5 and FBXO9 was confirmed through co-immunoprecipitation experiments, and it was shown that the TPR domain of FBXO9 is necessary for binding to DPPA5. The ubiquitination of DPPA5 by FBXO9 occurs specifically at the lysine residue K35, which is essential for its polyubiquitination and degradation. This process is significant for cellular reprogramming, as overexpression of DPPA5 enhances reprogramming efficiency, while a K35R mutation in DPPA5 reduces this efficiency (Swenson2024Ubiquitin).

DPPA5 is also part of a broader network of pluripotency-associated proteins, potentially interacting with key factors such as OCT4, SOX2, and NANOG, although specific physical interactions with these proteins are not detailed in the available context (MiangLon2011Embryonic).


## References


[1. (MiangLon2011Embryonic) Patricia Miang-Lon Ng and Thomas Lufkin. Embryonic stem cells: protein interaction networks. BioMolecular Concepts, 2(1–2):13–25, April 2011. URL: http://dx.doi.org/10.1515/bmc.2011.008, doi:10.1515/bmc.2011.008. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/bmc.2011.008)

[2. (Swenson2024Ubiquitin) Samantha A Swenson, Kasidy K Dobish, Hendrik C Peters, C Bea Winship, R Willow Hynes-Smith, Mika Caplan, Karli J Wittorf, Gargi Ghosal, and Shannon M Buckley. Ubiquitin e3 ligase fbxo9 regulates pluripotency by targeting dppa5 for ubiquitylation and degradation. Stem Cells, 42(4):317–328, January 2024. URL: http://dx.doi.org/10.1093/stmcls/sxae004, doi:10.1093/stmcls/sxae004. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/stmcls/sxae004)

[3. (Lagarkova2006Diverse) Maria A. Lagarkova, Pavel Y. Volchkov, Anna V. Lyakisheva, Elena S. Philonenko, and Sergei L Kiselev. Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle, 5(4):416–420, January 2006. URL: http://dx.doi.org/10.4161/cc.5.4.2440, doi:10.4161/cc.5.4.2440. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.5.4.2440)

[4. (Galán2010Functional) Amparo Galán, David Montaner, M. Eugenia Póo, Diana Valbuena, Verónica Ruiz, Cristóbal Aguilar, Joaquín Dopazo, and Carlos Simón. Functional genomics of 5- to 8-cell stage human embryos by blastomere single-cell cdna analysis. PLoS ONE, 5(10):e13615, October 2010. URL: http://dx.doi.org/10.1371/journal.pone.0013615, doi:10.1371/journal.pone.0013615. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0013615)